Influenza Vaccine Market Report

Global and Region Influenza Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：216
  • REPORT CODE：GMM947460
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.

    The European Center for Disease Prevention and Control recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.

    The report details the trend, potential and market size of Influenza Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Vaccinemarket, defines the market attractiveness level of Influenza Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenza Vaccine industry, describes the types of Influenza Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Vaccine market and the development prospects and opportunities of Influenza Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Vaccine market in Chapter 13.

    By Player:

    • Altimmune

    • CSL

    • UNM Pharma

    • GlaxoSmithKline

    • FluGen

    • SK Chemicals

    • Vaccitec

    • Sanofi

    • BionVax

    • AstraZeneca

    • Novavax

    • Genentech

    • Shijiazhuang Yiling Pharmaceutical

    • Green Cross

    • Moderna Therapeutics

    • Folia Biotech

    • Medicago

    By Type:

    • Fluzone/Vaxigrip

    • FluMist

    • Fluarix and Flulaval

    • Anflu

    • Fluvax/Afluria

    • Flucelvax and Fluvirin

    By End-User:

    • Adults

    • Pediatrics

    • Senior Citizens

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenza Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenza Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenza Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenza Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenza Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Influenza Vaccine Consumption (2017-2022)

    • 7.2 United States Influenza Vaccine Consumption (2017-2022)

    • 7.3 Europe Influenza Vaccine Consumption (2017-2022)

    • 7.4 China Influenza Vaccine Consumption (2017-2022)

    • 7.5 Japan Influenza Vaccine Consumption (2017-2022)

    • 7.6 India Influenza Vaccine Consumption (2017-2022)

    • 7.7 South Korea Influenza Vaccine Consumption (2017-2022)

    8 Region and Country-wise Influenza Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Influenza Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenza Vaccine Consumption Forecast (2022-2028)

    9 Global Influenza Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Fluzone/Vaxigrip Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global FluMist Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Fluarix and Flulaval Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Anflu Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Fluvax/Afluria Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Flucelvax and Fluvirin Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatrics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Senior Citizens Consumption and Growth Rate (2017-2022)

    10 Global Influenza Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenza Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Fluzone/Vaxigrip Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global FluMist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Fluarix and Flulaval Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Anflu Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Fluvax/Afluria Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Flucelvax and Fluvirin Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenza Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Senior Citizens Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenza Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenza Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenza Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenza Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenza Vaccine Market Competitive Analysis

    • 14.1 Altimmune

      • 14.1.1 Altimmune Company Details

      • 14.1.2 Altimmune Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Altimmune Influenza Vaccine Product and Service

    • 14.2 CSL

      • 14.2.1 CSL Company Details

      • 14.2.2 CSL Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 CSL Influenza Vaccine Product and Service

    • 14.3 UNM Pharma

      • 14.3.1 UNM Pharma Company Details

      • 14.3.2 UNM Pharma Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 UNM Pharma Influenza Vaccine Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Influenza Vaccine Product and Service

    • 14.5 FluGen

      • 14.5.1 FluGen Company Details

      • 14.5.2 FluGen Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 FluGen Influenza Vaccine Product and Service

    • 14.6 SK Chemicals

      • 14.6.1 SK Chemicals Company Details

      • 14.6.2 SK Chemicals Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 SK Chemicals Influenza Vaccine Product and Service

    • 14.7 Vaccitec

      • 14.7.1 Vaccitec Company Details

      • 14.7.2 Vaccitec Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Vaccitec Influenza Vaccine Product and Service

    • 14.8 Sanofi

      • 14.8.1 Sanofi Company Details

      • 14.8.2 Sanofi Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Influenza Vaccine Product and Service

    • 14.9 BionVax

      • 14.9.1 BionVax Company Details

      • 14.9.2 BionVax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BionVax Influenza Vaccine Product and Service

    • 14.10 AstraZeneca

      • 14.10.1 AstraZeneca Company Details

      • 14.10.2 AstraZeneca Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AstraZeneca Influenza Vaccine Product and Service

    • 14.11 Novavax

      • 14.11.1 Novavax Company Details

      • 14.11.2 Novavax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novavax Influenza Vaccine Product and Service

    • 14.12 Genentech

      • 14.12.1 Genentech Company Details

      • 14.12.2 Genentech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genentech Influenza Vaccine Product and Service

    • 14.13 Shijiazhuang Yiling Pharmaceutical

      • 14.13.1 Shijiazhuang Yiling Pharmaceutical Company Details

      • 14.13.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Product and Service

    • 14.14 Green Cross

      • 14.14.1 Green Cross Company Details

      • 14.14.2 Green Cross Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Green Cross Influenza Vaccine Product and Service

    • 14.15 Moderna Therapeutics

      • 14.15.1 Moderna Therapeutics Company Details

      • 14.15.2 Moderna Therapeutics Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Moderna Therapeutics Influenza Vaccine Product and Service

    • 14.16 Folia Biotech

      • 14.16.1 Folia Biotech Company Details

      • 14.16.2 Folia Biotech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Folia Biotech Influenza Vaccine Product and Service

    • 14.17 Medicago

      • 14.17.1 Medicago Company Details

      • 14.17.2 Medicago Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Medicago Influenza Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenza Vaccine

    • Figure Influenza Vaccine Picture

    • Table Global Influenza Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenza Vaccine Consumption by Country (2017-2022)

    • Figure United States Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluzone/Vaxigrip Consumption and Growth Rate (2017-2022)

    • Figure Global FluMist Consumption and Growth Rate (2017-2022)

    • Figure Global Fluarix and Flulaval Consumption and Growth Rate (2017-2022)

    • Figure Global Anflu Consumption and Growth Rate (2017-2022)

    • Figure Global Fluvax/Afluria Consumption and Growth Rate (2017-2022)

    • Figure Global Flucelvax and Fluvirin Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Senior Citizens Consumption and Growth Rate (2017-2022)

    • Figure Global Fluzone/Vaxigrip Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FluMist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluarix and Flulaval Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anflu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluvax/Afluria Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flucelvax and Fluvirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Senior Citizens Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenza Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenza Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Altimmune (Foundation Year, Company Profile and etc.)

    • Table Altimmune Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altimmune Influenza Vaccine Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Influenza Vaccine Product and Service

    • Table UNM Pharma (Foundation Year, Company Profile and etc.)

    • Table UNM Pharma Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table UNM Pharma Influenza Vaccine Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Influenza Vaccine Product and Service

    • Table FluGen (Foundation Year, Company Profile and etc.)

    • Table FluGen Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table FluGen Influenza Vaccine Product and Service

    • Table SK Chemicals (Foundation Year, Company Profile and etc.)

    • Table SK Chemicals Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Chemicals Influenza Vaccine Product and Service

    • Table Vaccitec (Foundation Year, Company Profile and etc.)

    • Table Vaccitec Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vaccitec Influenza Vaccine Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Influenza Vaccine Product and Service

    • Table BionVax (Foundation Year, Company Profile and etc.)

    • Table BionVax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table BionVax Influenza Vaccine Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Influenza Vaccine Product and Service

    • Table Novavax (Foundation Year, Company Profile and etc.)

    • Table Novavax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax Influenza Vaccine Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Influenza Vaccine Product and Service

    • Table Shijiazhuang Yiling Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Product and Service

    • Table Green Cross (Foundation Year, Company Profile and etc.)

    • Table Green Cross Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Green Cross Influenza Vaccine Product and Service

    • Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Moderna Therapeutics Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics Influenza Vaccine Product and Service

    • Table Folia Biotech (Foundation Year, Company Profile and etc.)

    • Table Folia Biotech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Folia Biotech Influenza Vaccine Product and Service

    • Table Medicago (Foundation Year, Company Profile and etc.)

    • Table Medicago Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicago Influenza Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US